2025 annual financial data
Immix Biopharma 2025 Financial results
Direct answer
Revenue was 0 USD.
Operating income was -29,956,415 USD and net income was -29,438,613 USD.
Operating cash flow was -23,930,304 USD.
Get free Immix Biopharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -29,956,415 USD
- Net income
- -29,438,613 USD
- Operating cash flow
- -23,930,304 USD
Explore related company data
View all 2025 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Net marginView Operating cash flow marginView all Immix Biopharma financial years